JNCE

Jounce Therapeutics, Inc. Common Stock

Delisted

JNCE was delisted on the 3rd of May, 2023.

88 hedge funds and large institutions have $125M invested in Jounce Therapeutics, Inc. Common Stock in 2020 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 20 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
88
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$448K
Puts
$216K
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
26
$710K
27
$696K
28
$514K
29
$507K
30
$501K
31
$499K
32
$480K
33
$439K
34
$380K
35
$351K
36
$350K
37
$335K
38
$323K
39
$314K
40
$294K
41
$267K
42
$251K
43
$238K
44
$235K
45
$235K
46
$229K
47
$210K
48
$209K
49
$203K
50
$198K